Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Healthcare Report.
Press releases published on June 4, 2025
Quadlytics Raises JPY 600 Million in Series A to Advance the Epileptic Seizure Prediction System
EIN Presswire
·
June 4, 2025
KYOTO, JAPAN, June 4, 2025 /EINPresswire.com/ -- Quadlytics Inc., headquartered in Kyoto, is a digital health company developing innovative medical devices. The company has raised JPY 300 million in equity funding through a Series A round led by Lifetime …
bonyf Welcomes Group Pharmaceuticals as Strategic Stakeholder to Drive Growth in India
EIN Presswire
·
June 4, 2025
bonyf is proud to announce that Group Pharmaceuticals (GP) has become a significant stakeholder in bonyf NV. GP has acquired a total of 13.5% of bonyf’s shares. bonyf NV (ENX:MLBON) KNOKKE-HEIST, KNOKKE-HEIST, BELGIUM, June 4, 2025 /EINPresswire.com/ …
Covasant Technologies Partners With Botminds to Help Global Enterprises Accelerate Agentic AI Adoption
EIN Presswire
·
June 4, 2025
Covasant …
Thyroid Eye Disease Treatment Market Poised for Disruption as Pipeline Therapies Target Tepezza’s | CI Insights
EIN Presswire
·
June 4, 2025
Emerging TED therapies aim to outpace Tepezza with safer, more convenient, and longer-lasting treatments. A market poised for evolution and innovation. AUSTIN, TX, UNITED STATES, June 4, 2025 /EINPresswire.com/ -- The Thyroid Eye Disease (TED) Market, …
Foundation for Sarcoidosis Research Announces 2025 Global Virtual Sarcoidosis Summit – United for Progress: A New Chapter in Sarcoidosis
GlobeNewswire
·
June 4, 2025
CHICAGO, June 04, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR), the leading international organization dedicated to finding a cure for sarcoidosis and improving patient support, is proud to announce the 2025 FSR Global Virtual …
Sutter Health Breaks Ground on $442 Million Neuroscience Complex in San Francisco
GlobeNewswire
·
June 4, 2025
SAN FRANCISCO, June 04, 2025 (GLOBE NEWSWIRE) -- Sutter Health today broke ground on the new Sutter Advanced Neuroscience Complex at Mission Bernal – a major milestone in expanding access to high-quality neurological and neurosurgical care in Northern …
Next-Generation Achondroplasia Therapies Set to Challenge Voxzogo’s Market Lead | Competitive Intelligence
EIN Presswire
·
June 4, 2025
Achondroplasia drug market sees rising competition, with weekly and oral treatments targeting improved convenience, adherence, and patient outcomes. AUSTIN, TX, UNITED STATES, June 4, 2025 /EINPresswire.com/ -- The therapeutic landscape for …
Decoding the Digital Lab with CSols—New Podcast Series for Industry Professionals
EIN Presswire
·
June 4, 2025
The first two episodes are available now: Unlocking Efficiency in Canadian Coal and Gas with LIMS and Squeezing the Pipette: Federal Funding Cuts and Your Lab NEWARK, DE, UNITED STATES, June 4, 2025 /EINPresswire.com/ -- CSols Inc., the leading North …
Assisted Living Market Size Expected To Reach USD 13.85 Billion in 2032, at a CAGR of 7.3% from 2025 to 2032
EIN Presswire
·
June 4, 2025
The Assisted Living Market Its total industry revenue is expected to grow by 7.3 % from 2025 to 2032, reaching nearly USD 13.85 billion in 2032. ORLANDO, FL, UNITED STATES, June 4, 2025 /EINPresswire.com/ -- The global Assisted Living Market will …
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 4, 2025
BOSTON, June 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …
MarkHerz Signs MOU with TUM Hospital for Joint Development of Cardiovascular and Diabetes-Targeted AAV Gene Therapies
EIN Presswire
·
June 4, 2025
MarkHerz Signs MOU with TUM Hospital for Joint Development of Cardiovascular and Diabetes-Targeted AAV Gene Therapies MUNICH, BAYERN, GERMANY, June 4, 2025 /EINPresswire.com/ -- Paving the Way for European Clinical Entry and Global Technology Transfer …
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025
GlobeNewswire
·
June 4, 2025
Information regarding the total number of voting rights and total number of shares of the Company as of May 30, 2025 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) …
Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 mai 2025
GlobeNewswire
·
June 4, 2025
Information relative au …
Digital Breast Tomosynthesis (DBT) Equipment Market to Grow from USD 3.26 Billion in 2025 to USD 7.66 Billion by 2035
EIN Presswire
·
June 4, 2025
Digital Breast Tomosynthesis Market to Reach USD 7.66 Billion by 2035 at 8.9% CAGR NEW YORK, DE, UNITED STATES, June 4, 2025 /EINPresswire.com/ -- The global digital breast tomosynthesis (DBT) equipment market is estimated to be valued at USD 3.26 …
SI-BONE to Truist Securities MedTech Conference on June 17, 2025
GlobeNewswire
·
June 4, 2025
SANTA CLARA, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming 2025 Truist Securities MedTech …
Royalty Pharma to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
June 4, 2025
NEW YORK, June 04, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2025 at 2:00 p.m. ET. The webcast …
NeuroPace Secures Up to $75 Million in Debt Financing
GlobeNewswire
·
June 4, 2025
MOUNTAIN VIEW, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that the Company has entered into a new $75 million credit …
Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
GlobeNewswire
·
June 4, 2025
SOUTH SAN FRANCISCO, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer, announced today that members of its …
89bio to Participate in Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
June 4, 2025
SAN FRANCISCO, June 04, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and …
Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes
GlobeNewswire
·
June 4, 2025
GERMANTOWN, Md., June 04, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people …